Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells.

[1]  Ryan L. Collins,et al.  Mutations causing Lopes-Maciel-Rodan Syndrome are huntingtin hypomorphs. , 2021, Human molecular genetics.

[2]  A. Durr,et al.  PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study , 2020, Journal of Neurology.

[3]  A. Durr,et al.  Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice , 2020, EMBO molecular medicine.

[4]  Zhaohui S. Qin,et al.  Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form , 2020, Nature Communications.

[5]  H. D. Rosas,et al.  Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease , 2020, Neurology: Genetics.

[6]  C. Gellera,et al.  Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population , 2020, Neurological Sciences.

[7]  H. Yin,et al.  Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival. , 2020, Cell reports.

[8]  Yu Ding,et al.  Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds , 2019, Nature.

[9]  A. Pastore,et al.  The Role of Post-translational Modifications on the Energy Landscape of Huntingtin N-Terminus , 2019, Front. Mol. Biosci..

[10]  Jane S. Paulsen,et al.  CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset , 2019, Cell.

[11]  S. Zapperi,et al.  Molecular mechanisms of heterogeneous oligomerization of huntingtin proteins , 2019, Scientific Reports.

[12]  R. Barker,et al.  Targeting Huntingtin Expression in Patients with Huntington's Disease. , 2019, The New England journal of medicine.

[13]  G. Bates,et al.  Meso scale discovery-based assays for the detection of aggregated huntingtin , 2019, PloS one.

[14]  R. Langen,et al.  The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract , 2018, The Journal of Biological Chemistry.

[15]  H. Lashuel,et al.  N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting , 2018, The Journal of Biological Chemistry.

[16]  C. Ross,et al.  N6-Furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylation , 2018, Proceedings of the National Academy of Sciences.

[17]  P. McColgan,et al.  Huntington's disease: a clinical review , 2018, European journal of neurology.

[18]  J. Marsh,et al.  Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation , 2017, Proceedings of the National Academy of Sciences.

[19]  C. Ross,et al.  Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity , 2017, The Journal of Biological Chemistry.

[20]  J. Marsh,et al.  Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models , 2017, Scientific Reports.

[21]  M. Levitt,et al.  Emerging β-Sheet Rich Conformations in Supercompact Huntingtin Exon-1 Mutant Structures. , 2017, Journal of the American Chemical Society.

[22]  F. Giorgini,et al.  Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity , 2017, bioRxiv.

[23]  A. Pastore,et al.  Mutant Exon1 Huntingtin Aggregation is Regulated by T3 Phosphorylation-Induced Structural Changes and Crosstalk between T3 Phosphorylation and Acetylation at K6. , 2017, Angewandte Chemie.

[24]  S. Valentine,et al.  Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding. , 2016, Biophysical journal.

[25]  K. Khodakhah,et al.  Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington’s disease , 2016, Proceedings of the National Academy of Sciences.

[26]  Shihua Li,et al.  Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis , 2016, Proceedings of the National Academy of Sciences.

[27]  S. Humbert,et al.  The Biology of Huntingtin , 2016, Neuron.

[28]  A. Caricasole,et al.  Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy , 2014, PloS one.

[29]  Yu Ding,et al.  TR-FRET Assays of Huntingtin Protein Fragments Reveal Temperature and PolyQ Length-Dependent Conformational Changes , 2014, Scientific Reports.

[30]  R. Cole,et al.  Phosphorylation of Mutant Huntingtin at Serine 116 Modulates Neuronal Toxicity , 2014, PloS one.

[31]  R. Truant,et al.  Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin , 2013, Proceedings of the National Academy of Sciences.

[32]  O. Riess,et al.  Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice , 2013, PloS one.

[33]  M. Diamond,et al.  An N-terminal Nuclear Export Signal Regulates Trafficking and Aggregation of Huntingtin (Htt) Protein Exon 1* , 2013, The Journal of Biological Chemistry.

[34]  R. Wetzel,et al.  Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties. , 2012, Journal of molecular biology.

[35]  Anne E Carpenter,et al.  Advanced Assay Development Guidelines for Image-Based High Content Screening and Analysis , 2012 .

[36]  N. Jetté,et al.  The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis , 2012, Movement disorders : official journal of the Movement Disorder Society.

[37]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[38]  L. Kaltenbach,et al.  TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease. , 2012, Chemistry & biology.

[39]  K. Fouad,et al.  Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice , 2012, Proceedings of the National Academy of Sciences.

[40]  R. Atwal,et al.  Kinase inhibitors modulate huntingtin cell localization and toxicity. , 2011, Nature chemical biology.

[41]  C. McMurray.  Mechanisms of trinucleotide repeat instability during human development , 2010, Nature Reviews Genetics.

[42]  Andreas Vitalis,et al.  Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. , 2010, Journal of molecular biology.

[43]  S. Finkbeiner,et al.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome , 2009, The Journal of cell biology.

[44]  S. Finkbeiner,et al.  Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice , 2009, Neuron.

[45]  D. Rubinsztein,et al.  Huntington's disease: from pathology and genetics to potential therapies. , 2008, The Biochemical journal.

[46]  J. Olson,et al.  Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration , 2007, PLoS genetics.

[47]  Michael P. Cusack,et al.  Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry , 2006, Journal of Biological Chemistry.

[48]  L. Raymond,et al.  Canadian Association of Neurosciences Review: Polyglutamine Expansion Neurodegenerative Diseases , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[49]  B. Harper.  Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[50]  D. Rubinsztein,et al.  Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases , 2005, The Journal of cell biology.

[51]  Karen Marder,et al.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Xiao-Jiang Li,et al.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease. , 2004, Trends in genetics : TIG.

[53]  P. Patterson,et al.  New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins , 2001, Brain Research Bulletin.

[54]  M. MacDonald,et al.  The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. , 2001, Human molecular genetics.

[55]  H. Lashuel,et al.  Towards deciphering the Nt17 code: How the sequence and conformation of the first 17 amino acids in Huntingtin regulate the aggregation, cellular properties and neurotoxicity of mutant Httex1 , 2021 .

[56]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.